• January 2024
• Supplement

Accounting Red Flags or Red Herrings at Catalent? (B)

By: Joseph Pacelli, ZeSean Ali and Tom Quinn

GlassHouse Research identified accounting red flags at Catalent. Fiat Lux Partners countered most of GlassHouse’s claims. Who was right? This update explores the aftermath of the short seller duel. View Details

Keywords: Accounting Audits; Acquisition; Budgets and Budgeting; Business Earnings; Earnings Management; Cost Accounting; Fair Value Accounting; Financial Reporting; Revenue Recognition; Integrated Corporate Reporting; Fairness; Moral Sensibility; Values and Beliefs; Government Legislation; Conflict of Interests; Announcements; Blogs; Debates; Lawsuits and Litigation; Stocks; Performance Productivity; Pharmaceutical Industry; Pharmaceutical Industry; United States

Citation

Purchase

Related

Pacelli, Joseph, ZeSean Ali, and Tom Quinn. "Accounting Red Flags or Red Herrings at Catalent? (B)." Harvard Business School Supplement 124-055, January 2024.

• Web

HBS - The year in Review

2023 Annual Report From The Dean Key Metrics Financials PDF Downloads The Year in Review Notable progress was made during FY23 in advancing the School’s priorities. Accelerating research on how digital and data are transforming management... View Details

• Research Summary

Overview

I am interested in the individual experience of learning in organizational settings, particularly how employees learn to learn from the challenging work they do. I am currently researching the role of reflection for raising awareness of learning opportunities that... View Details

Keywords: Learning; Learning And Development; Learning Organizations; Intrinsic Motivation; Reflection; Goal Setting; Performance Measurement; Innovation; Job Design; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry

• March 2011 (Revised June 2012)
• Case

Office of Technology Transfer - Shanghai Institutes for Biological Sciences

By: Willy Shih, Sen Chai, Kamen Bliznashki and Courtney Hyland

Gordon Zong is trying to teach Chinese universities and research institutes how to do effective technology transfer and IP licensing, but he is trying to do it in an environment with weak property rights and an underdeveloped support infrastructure. As the managing... View Details

Keywords: Multinational Firms and Management; Patents; Knowledge Management; Law Enforcement; Business and Government Relations; Research and Development; Pharmaceutical Industry; Pharmaceutical Industry; China

Citation

Educators

Purchase

Related

Shih, Willy, Sen Chai, Kamen Bliznashki, and Courtney Hyland. "Office of Technology Transfer - Shanghai Institutes for Biological Sciences." Harvard Business School Case 611-057, March 2011. (Revised June 2012.)

• 22 Apr 2014
• First Look

First Look: April 22

Nava, Diego Aycinena, Claudia Martínez A., and Dean Yang Abstract—While remittance flows to developing countries are very large, it is unknown whether migrants desire more control over how remittances are used. This research uses a... View Details

Keywords: Sean Silverthorne

• February 2010 (Revised April 2010)
• Case

Organization and Strategy at Millennium (A)

By: Julie M. Wulf and Scott Waggoner

This case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark... View Details

Keywords: Transformation; Leading Change; Management Succession; Organizational Change and Adaptation; Competitive Strategy; Competitive Advantage; Pharmaceutical Industry; Pharmaceutical Industry

Citation

Educators

Purchase

Related

Wulf, Julie M., and Scott Waggoner. "Organization and Strategy at Millennium (A)." Harvard Business School Case 710-415, February 2010. (Revised April 2010.)

• 23 Jul 2001
• Research & Ideas

How Relationships are Building Biotech

networks—have in large part been borne out by her subsequent in-depth research. Though Higgins clarifies that her results so far on the biotech industry reflect the early stages of a long research project, she has already hit on some... View Details

Keywords: by Martha Lagace & Mallory Stark

• 17 Jun 2002
• Research & Ideas

Entrepreneurship in Asia and Foreign Direct Investment

worried about the ascendance of China, while firms in Taiwan and Hong Kong have reaped enormous benefits from Chinese economic expansion, according to Huang. He presented his new research proposal to an audience of faculty and doctoral... View Details

Keywords: by Martha Lagace

• September 2022
• Article

Find and Replace: R&D Investment Following the Erosion of Existing Products

By: Joshua L. Krieger, Xuelin Li and Richard T. Thakor

How do innovative firms react when existing products experience negative shocks? We explore this question with detailed project-level data from drug development firms. Using FDA Public Health Advisories as idiosyncratic negative shocks to approved drugs, we first... View Details

Keywords: R＆D Investments; Drug Development; Product Shocks; M＆A; Biopharmaceutical Industry; FDA; System Shocks; Research and Development; Investment; Decision Making; Pharmaceutical Industry

Citation

SSRN

Find at Harvard

Read Now

Related

Krieger, Joshua L., Xuelin Li, and Richard T. Thakor. "Find and Replace: R&D Investment Following the Erosion of Existing Products." Management Science 68, no. 9 (September 2022): 6552–6571.

• 24 May 2011
• First Look

First Look: May 24

perspective that Porter has taken, often as a result of his specific background and prior research interests. The chapter then turns to extensions of these core concepts in Porter's more recent work. A central focus of this work has been... View Details

Keywords: Sean Silverthorne

• 13 Jul 2020
• Research & Ideas

Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk

As chairman and CEO of the leading vaccine producer in the world, pharmaceutical giant Merck & Co., Ken Frazier has one of the highest-profile positions in global business. But Frazier, who is leading one of the firms on a charge to... View Details

Keywords: by Staff; Pharmaceutical